The Research

Online sales and importation of Mifeprex for home use carries substantial risks.

A study, published in September 2018, of nearly 5,000 women who underwent abortions in Sweden found that complications are more frequent when women abort at home, without the oversight of a healthcare provider.

A retrospective analysis of 754 cases involving the use of progesterone to reverse the effects of the first dose of Mifeprex has found that the reversal process is safe and effective.

A preliminary look at state abortion data from 2017 shows that abortion trends are changing and that chemical abortion is on the rise: